HER2-positive Breast Cancer Registry
ConditionHER2 + Breast Cancer
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorPriyanka Sharma
About this trial
The goal of this observational study is to better understand links between patient or tumor characteristics and outcomes in HER2-positive breast cancer.
Eligibility criteria
Qualifiers
Stage I-IV HER2-positive breast cancer
Disqualifiers
None
Trial design
Treatments tested in this trial
- Not listed
Trial groups
1,000 Participants
are grouped into 1 trial groupSponsors and collaborators
Priyanka Sharma
Lead sponsor
University of Kansas Medical Center
Sponsor institution
Source ClinicalTrials.gov